Kim Brosen researcher
Brøsen, Kim
Brøsen, Kim, 19..-....
VIAF ID: 28299200 (Personal)
Permalink: http://viaf.org/viaf/28299200
Preferred Forms
- 100 1 _ ‡a Brøsen, Kim
-
-
-
- 100 1 _ ‡a Brøsen, Kim
- 100 1 _ ‡a Brøsen, Kim, ‡d 19..-....
- 100 0 _ ‡a Kim Brosen ‡c researcher
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Abstract book | |
Basal og klinisk farmakologi | |
Danske forskere publicerer i fuptidsskrifter | |
Genetic predisposition to Parkinson's disease: CYP2D6 and HFE in the Faroe Islands. | |
[The genome and pharmacology] | |
Genotypes for the cytochrome P450 enzymes CYP2D6 and CYP2C19 in human longevity | |
Griseofulvin and fluvoxamine interactions with the metabolism of theophylline. | |
HPLC Method for Determination of Rosiglitazone in Plasma | |
The hypoalgesic effect of imipramine in different human experimental pain models | |
The hypoalgesic effect of tramadol in relation to CYP2D6* | |
Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer | |
The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide | |
Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake | |
Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia | |
In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids | |
In vitro metabolism of genistein and tangeretin by human and murine cytochrome P450s | |
In Vivo Imaging of Human 11C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses. | |
Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine | |
Inhibitory effect of oral contraceptives on CYP2C19 activity is not significant in carriers of the CYP2C19*17 allele | |
Initiation of glucose-lowering treatment decreases international normalized ratio levels among users of vitamin K antagonists: a self-controlled register study. | |
Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone | |
Interaction between tramadol and phenprocoumon | |
Interaktion mellem carbamazepin og østrogen | |
The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors | |
Lack of Association ofOPRM1andABCB1Single-Nucleotide Polymorphisms to Oxycodone Response in Postoperative Pain | |
Lægemiddelinteraktioner ved behandling med antidepressiva | |
Letter from the Editor | |
Limited sampling strategy for determining metformin area under the plasma concentration-time curve | |
Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations | |
Metformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetes | |
Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study* | |
A multifamily study on the relationship between CYP2C19 genotype and S-mephenytoin oxidation phenotype | |
Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinoma | |
Open letter on access to the BIA 10-2474 clinical trial data | |
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors. | |
Pharmacogenetics | |
Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers | |
Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients | |
Pharmacokinetics of metformin in patients with gastrointestinal intolerance. | |
A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24 | |
Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population. | |
Philippe Grandjean is the 2015 BCPT Nordic Prize Awardee. | |
Polychlorinated biphenyl (PCB) induction of CYP3A4 enzyme activity in healthy Faroese adults. | |
Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population | |
Preface | |
Probe Depth Matters in Dermal Microdialysis Sampling of Benzoic Acid after Topical Application: An ex vivo Study in Human Skin | |
Professor Folke Fritz Adolf Sjöqvist (28 May 1933-30 March 2020) | |
Professor Jens Sølver Schou 10 October 1929-8 March 2017. | |
Professor Thue W. Schwartz is the BCPT Nordic Prize Winner 2017 in Basic & Clinical Pharmacology & Toxicology. | |
Quantification of morphine, morphine 6-glucuronide, buprenorphine, and the enantiomers of methadone by enantioselective mass spectrometric chromatography in whole blood | |
Quantitative Determination of Tolbutamide and Its Metabolites in Human Plasma and Urine by High-Performance Liquid Chromatography and UV Detection | |
Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6. | |
The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers. | |
Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel--letter. | |
Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide | |
Risk factors in elderly taking psychotropic drugs: Significance of genetic polymorphism in drug oxidation | |
Role of cytochrome P450 2C8*3 (CYP2C8*3) in paclitaxel metabolism and paclitaxel-induced neurotoxicity. | |
The role of genetic variants in CYP2C8, LPIN1, PPARGC1A and PPARγ on the trough steady-state plasma concentrations of rosiglitazone and on glycosylated haemoglobin A1c in type 2 diabetes | |
The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms | |
Some aspects of genetic polymorphism in the biotransformation of antidepressants | |
The sparteine/debrisoquine | |
Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women | |
Tacrine is not an ideal probe drug for measuring CYP1A2 activity in vivo | |
Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study | |
Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. | |
Use of Dicloxacillin and Risk of Pregnancy among Users of Oral Contraceptives | |
[The use of the monoamine oxidase inhibitor isocarboxazide in treatment-resistant depression]. | |
Using a limited sampling strategy (LSS) to investigate the interindividual pharmacokinetic variability in metformin - a large prospective trial | |
Using a semi-mechanistic model to identify the main sources of variability of metformin pharmacokinetics | |
Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis. | |
A ¤guide to training in clinical pharmacology in Europe | |
The ¤relationship between imipramine metabolism and the sparteine oxidation polymorphism | |
মুখবন্ধ |